Home > Boards > US Listed > Biotechs > Aduro Biotech (KDNY)

Especially at $48. IPO was $17 REMEMBER

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
rtraster Member Profile
 
Followed By 6
Posts 245
Boards Moderated 0
Alias Born 09/05/13
160x600 placeholder
Chinook Therapeutics to Present at the William Blair Biotech Focus Conference 2021 GlobeNewswire Inc. - 7/12/2021 4:05:00 PM
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 7/7/2021 4:05:00 PM
Geron, AnPac Bio-Medical Science leads healthcare gainers; Orphazyme, Athira Pharma among major losers Seeking Alpha - 6/18/2021 11:01:18 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/18/2021 6:06:18 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2021 6:40:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/15/2021 5:26:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2021 6:15:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2021 4:23:43 PM
Chinook Therapeutics names new COO and CSO Seeking Alpha - 6/9/2021 8:24:53 AM
Chinook Therapeutics Announces Promotions of Tom Frohlich to Chief Operating Officer and Andrew King, D.V.M, Ph.D., to Chief ... GlobeNewswire Inc. - 6/9/2021 8:15:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2021 6:08:10 PM
Chinook Therapeutics Presents BION-1301 Interim Phase 1/2 Data in Patients with IgA Nephropathy (IgAN) at the 58th ERA-EDTA V... GlobeNewswire Inc. - 6/8/2021 8:15:00 AM
Chinook Therapeutics to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 58th ERA-EDTA Congress GlobeNewswire Inc. - 5/25/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/18/2021 5:02:13 PM
Chinook Therapeutics to Present at the 2021 RBC Capital Markets Global Healthcare Conference GlobeNewswire Inc. - 5/13/2021 4:05:00 PM
Chinook Therapeutics EPS misses by $0.24, beats on revenue Seeking Alpha - 5/12/2021 4:46:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/12/2021 4:10:58 PM
Chinook Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results GlobeNewswire Inc. - 5/12/2021 4:05:00 PM
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 5/4/2021 4:15:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/23/2021 4:11:59 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/23/2021 4:08:39 PM
Chinook Therapeutics Presents Data During the ISN World Congress of Nephrology 2021 GlobeNewswire Inc. - 4/15/2021 8:15:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/15/2021 7:41:06 AM
Chinook Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 4/8/2021 4:30:00 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/7/2021 5:29:13 PM
rtraster   Thursday, 04/16/15 10:44:06 AM
Re: rtraster post# 20
Post # of 106 
Especially at $48. IPO was $17 REMEMBER

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences